查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786584

全球生育旅遊市場

Fertility Tourism
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 287 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年全球生育旅遊市場規模將達53億美元

全球生育旅遊市場規模預計在2024年達到15億美元，預計2024年至2030年期間的複合年成長率為23.1%，到2030年將達到53億美元。捐卵子治療是本報告分析的細分市場之一，預計其複合年成長率將達到26.5%，到分析期結束時規模將達到21億美元。自體卵子體外受精治療細分市場在分析期間的複合年成長率預計為22.3%。

美國市場規模估計為 4.15 億美元，中國市場預計複合年成長率為 31.2%

美國的戀物癖旅遊市場規模預計在2024年達到4.15億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到13億美元，在2024-2030年的分析期間內，複合年成長率將達到31.2%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為18.2%和20.9%。在歐洲，預計德國市場的複合年成長率約為19.5%。

全球生育旅遊市場－主要趨勢與促進因素摘要

為什麼生育旅遊會成為跨國生育希望的生命線？

隨著個人和夫婦出國尋求輔助生殖技術 (ART)，如體外受精、捐卵子、代孕和捐精，生育旅遊 (也稱為生殖醫學或跨境生殖醫學) 經歷了顯著成長。在成本、可用性、法律體制和成功率差異的推動下，這一全球趨勢催生了醫療旅遊這一蓬勃發展的子部門行業，將醫療保健服務與國際旅行結合在一起。由於本國的限制，例如禁止商業性代孕、年齡和婚姻狀況限制以及對 LGBTQ+ 家庭組成的限制，生育遊客通常會在更寬鬆的目的地尋求治療。印度、烏克蘭、西班牙、希臘、美國等國家已成為提供全面且相對實惠的生育治療服務的重要中心，吸引了來自西歐、北美、中東和亞洲的患者。雖然情感和經濟風險很高，但生育旅遊結合了優質的醫療服務、謹慎的態度、短暫的等待時間和法律保護，在全球生殖健康領域越來越受到追捧。

影響生育旅遊熱點的法律和道德背景是什麼？

法律架構和倫理考量是全球生育旅遊生態系統的核心，通常決定病人前往何處接受治療。對輔助生殖技術（ART）監管較為寬鬆的國家，包括匿名捐卵子和捐精、妊娠代孕和非醫療胚胎冷凍，正成為國際患者的首選。例如，西班牙和捷克共和國因其合法的匿名性和捐卵者的可近性而成為捐卵子試管受精（IVF）的熱門國家，而墨西哥和哥倫比亞則因其經濟實惠的代孕選擇和患者友好的法律而日益受到青睞。同時，德國、法國、中國以及中東部分地區等國家嚴格或不斷演變的法規，正促使人們尋求海外服務。倫理方面的擔憂，尤其是在商業性代孕、剝削和知情同意方面，促使印度和泰國等國家進行了改革，導致一些服務不再面向外國人，並引入了更嚴格的監管。這些法律體系的變化為生育診所和機構帶來了挑戰和機會，包括合規性、跨境父母權利的法律授權以及對代孕者和捐卵者的倫理待遇。在選擇生育治療目的地時，患者越來越重視法律的明確性、醫療標準和道德保障，而不僅僅是負擔能力。

人口統計、社會規範和可及性在市場擴張中扮演什麼角色？

不斷變化的社會規範、人口趨勢和生殖挑戰正在刺激全球對生育旅遊的需求。由於生活方式因素、延遲生育、環境影響和慢性病發病率上升，不孕症上升，促使人們跨境尋求生殖保健。同時，人們對非傳統家庭結構（如同同性伴侶、自願單親父母和尋求父母身份的老年人）的接受度不斷提高，正在擴大 ART 服務的需求基礎。許多這樣的病患小組在其祖國面臨法律或製度障礙，這使得更容易獲得生育治療的國家更具吸引力。可近性的提高，例如簡化的醫療遊客簽證流程、多語言生育協調員和捆綁治療方案，也正在消除後勤障礙。遠端醫療、遠距諮詢和數位生育監測應用程式的技術進步正在幫助患者從遠處開始病人歷程，減少最初的障礙並提高透明度。此外，社群媒體、線上論壇和生育領域的影響者正在提升全球對各種生育選擇的認知，促進P2P學習和主導經驗的決策。隨著生育願望日益超越國界，這些社會和人口結構的變化正使生育旅遊成為一種個人解決方案，同時也是一個日益壯大的全球產業。

哪些因素推動了全球生育旅遊市場的成長？

生育旅遊市場的成長受到多種因素的驅動，這些因素源自於醫療保健的全球化、成本差異、人口結構變化和跨境法律差異。即使將旅行和住宿費用計算在內，印度、烏克蘭和喬治亞等國的 IVF 和代孕費用也比美國和英國便宜 70%。同時，在加拿大和英國等國的公共醫療系統中，輔助生殖技術 (ART) 服務的等待時間較長，這促使患者要求更快地獲得出國治療服務。除了政府對醫療旅遊的戰略支持外，出國目的地國 ART 法律的自由化也透過改善基礎設施和國際患者服務促進了成長。不孕症患者數量不斷增加，尤其是在都市區，這擴大了患者群，而生育治療實驗室的技術標準化確保了知名國際診所的成功率始終如一。此外，生育機構、禮賓服務和國際代孕網路的日益壯大，促進了端到端的協調，包括旅行、法律合約和治療後護理。最後，在計劃團體、有影響力人士和名流，人們對生殖問題的日益開放，正在消除輔助生殖技術（ART）的污名化，促進跨國需求激增，並鞏固生育旅遊作為未來生殖保健重要解決方案的地位。

部分

治療（捐卵子治療、自體卵子試管嬰兒治療、代孕治療、捐卵治療、捐精治療）；年齡層（18-24、25-34、35-44、45-54）

受訪公司範例

  • Bangkok Hospital
  • Barbados Fertility Centre
  • BioTexCom Center for Human Reproduction
  • Bourn Hall Clinic
  • Clinica Tambre
  • Copenhagen Fertility Center
  • Dunya IVF Clinic
  • Embryolab Fertility Clinic
  • Fertility Associates
  • Fertility Center Mexico
  • Fertility First
  • GREFI（Grupo de Fertilidad y Ginecologia）
  • IVI Fertility
  • Life Clinic Athens
  • Medfem Fertility Clinic
  • NewLife IVF
  • North Cyprus IVF Centre
  • Nova IVF Fertility
  • Reprofit International
  • Sanatorium HELIOS

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP30924

Global Fertility Tourism Market to Reach US$5.3 Billion by 2030

The global market for Fertility Tourism estimated at US$1.5 Billion in the year 2024, is expected to reach US$5.3 Billion by 2030, growing at a CAGR of 23.1% over the analysis period 2024-2030. Donor Egg Treatment, one of the segments analyzed in the report, is expected to record a 26.5% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the IVF With Own Egg Treatment segment is estimated at 22.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$415.0 Million While China is Forecast to Grow at 31.2% CAGR

The Fertility Tourism market in the U.S. is estimated at US$415.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 31.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.2% and 20.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 19.5% CAGR.

Global Fertility Tourism Market - Key Trends & Drivers Summarized

Why Is Fertility Tourism Emerging as a Cross-Border Lifeline for Reproductive Hope?

Fertility tourism-also known as reproductive or cross-border reproductive care-is witnessing significant growth as individuals and couples travel abroad in pursuit of assisted reproductive technologies (ART) like IVF, egg donation, surrogacy, and sperm donation. Driven by disparities in cost, availability, legal frameworks, and success rates, this global movement is giving rise to a thriving medical tourism sub-sector that blends healthcare access with international travel. Many turn to fertility tourism due to restrictive regulations in their home countries-such as bans on commercial surrogacy, age or marital status limits, or constraints on LGBTQ+ family-building-compelling them to seek treatment in more permissive destinations. Countries like India, Ukraine, Spain, Greece, Mexico, and the United States have emerged as key hubs offering comprehensive and comparatively affordable fertility services, attracting patients from Western Europe, North America, the Middle East, and Asia. The emotional and financial stakes are high, and the ability to combine high-quality medical care with discretion, reduced waiting times, and legal protection has made fertility tourism an increasingly sought-after solution in the global reproductive health landscape.

How Are Legal and Ethical Landscapes Shaping Fertility Tourism Hotspots?

Legal frameworks and ethical considerations are central to the global fertility tourism ecosystem, often determining where patients choose to travel for treatment. Countries with liberal ART regulations-allowing procedures like anonymous egg/sperm donation, gestational surrogacy, and embryo freezing for non-medical reasons-are becoming top choices for international patients. For instance, Spain and the Czech Republic are preferred for donor egg IVF due to legal anonymity and donor availability, while Mexico and Colombia have gained traction for affordable surrogacy options and patient-friendly laws. Meanwhile, restrictive or evolving regulations in countries like Germany, France, China, and parts of the Middle East are pushing individuals to seek services abroad. Ethical concerns-especially around commercial surrogacy, exploitation, and informed consent-have prompted reforms in countries like India and Thailand, leading to the closure of some services to foreigners or the introduction of stricter oversight. These shifting legal terrains create both challenges and opportunities for fertility clinics and agencies, who must navigate compliance, cross-border legal recognition of parental rights, and the ethical treatment of surrogates and donors. Increasingly, patients are prioritizing not just affordability, but also legal clarity, medical standards, and ethical safeguards when choosing a destination for fertility care.

What Role Are Demographics, Social Norms, and Accessibility Playing in Market Expansion?

Changing social norms, demographic trends, and reproductive challenges are fueling global demand for fertility tourism. The rise in infertility rates-driven by lifestyle factors, delayed childbearing, environmental influences, and rising rates of chronic conditions-is prompting individuals to explore reproductive care across borders. Meanwhile, growing acceptance of non-traditional family structures, including same-sex couples, single parents by choice, and older individuals seeking parenthood, is widening the demand base for ART services. Many of these patient groups face legal or institutional barriers in their home countries, making fertility-friendly nations more attractive. Accessibility improvements, such as streamlined visa processes for medical tourists, multilingual fertility coordinators, and bundled treatment packages, are also removing logistical obstacles. Technological advancements in telehealth, remote consultations, and digital fertility monitoring apps are helping patients begin their journey from afar, reducing initial barriers and enhancing transparency. Furthermore, social media, online forums, and fertility influencers are increasing awareness about global options, enabling peer-to-peer learning and testimonial-driven decision-making. As reproductive aspirations increasingly transcend borders, these social and demographic shifts are establishing fertility tourism as both a personal solution and a growing global industry.

What Are the Core Growth Drivers Accelerating the Fertility Tourism Market Globally?

The growth in the Fertility Tourism market is driven by several factors rooted in medical globalization, cost differentials, demographic shifts, and legal divergence across borders. One of the primary drivers is the significant variation in treatment costs-IVF and surrogacy procedures in countries like India, Ukraine, and Georgia can be up to 70% less expensive than in the U.S. or U.K., even after accounting for travel and accommodation. At the same time, long waiting periods for ART services in public healthcare systems across countries like Canada and the U.K. are prompting patients to seek faster access abroad. The liberalization of ART laws in destination countries, alongside strategic government support for medical tourism, is also contributing to growth by improving infrastructure and international patient services. Rising infertility prevalence, particularly in urban populations, is expanding the patient pool, while technological standardization in fertility labs ensures consistent success rates across reputable international clinics. Additionally, the growing presence of fertility agencies, concierge services, and international surrogacy networks is facilitating smoother end-to-end coordination of travel, legal contracts, and post-treatment care. Finally, increased openness around reproductive challenges-supported by advocacy groups, influencers, and celebrities-has de-stigmatized ART and created a demand surge that crosses national borders, reinforcing fertility tourism’s status as a vital solution in the future of reproductive healthcare.

SCOPE OF STUDY:

The report analyzes the Fertility Tourism market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment, Sperm Donation Treatment); Age Group (18-24, 25-34, 35-44, 45-54)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Bangkok Hospital
  • Barbados Fertility Centre
  • BioTexCom Center for Human Reproduction
  • Bourn Hall Clinic
  • Clinica Tambre
  • Copenhagen Fertility Center
  • Dunya IVF Clinic
  • Embryolab Fertility Clinic
  • Fertility Associates
  • Fertility Center Mexico
  • Fertility First
  • GREFI (Grupo de Fertilidad y Ginecologia)
  • IVI Fertility
  • Life Clinic Athens
  • Medfem Fertility Clinic
  • NewLife IVF
  • North Cyprus IVF Centre
  • Nova IVF Fertility
  • Reprofit International
  • Sanatorium HELIOS

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Fertility Tourism - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • High Cost of Fertility Treatments in Developed Nations Throws the Spotlight on Cross-Border Reproductive Options
    • Long Wait Times and Access Barriers Spur Demand for Affordable and Timely Fertility Care Abroad
    • Expanding Legalization of Surrogacy and Egg Donation in Select Countries Strengthens the Business Case for Fertility Tourism
    • Favorable Government Policies and Medical Infrastructure in Destination Countries Propel Growth of Reproductive Travel
    • Growing Awareness Through Online Communities and Medical Tourism Platforms Drives Patient Mobility Across Borders
    • Increasing Demand for Donor Gametes and Advanced ART Techniques Generates Opportunities in Specialized Fertility Clinics Abroad
    • LGBTQ+ and Single Parent Family Planning Needs Expand the Addressable Market for Inclusive Fertility Tourism Services
    • Rising Infertility Rates and Delayed Parenthood Trends Sustain Global Demand for Accessible Reproductive Solutions
    • Global Accreditation and Quality Certifications Build Trust and Standardization Across Cross-Border Clinics
    • Cultural Acceptance and Language Support Services Enhance Patient Comfort in Foreign Treatment Destinations
    • Technological Advancements in Remote Fertility Consultations Drive Pre- and Post-Treatment Integration Across Geographies
    • Ethical and Legal Complexities Around Surrogacy and Embryo Transport Create Regulatory Hurdles but Also Push for Reform
    • Rising Interest in Egg Freezing and Fertility Preservation Fuels Medical Travel Among Career-Oriented Individuals
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Fertility Tourism Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Fertility Tourism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Fertility Tourism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Fertility Tourism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Donor Egg Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Donor Egg Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Donor Egg Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for IVF With Own Egg Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for IVF With Own Egg Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for IVF With Own Egg Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Surrogacy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Surrogacy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Surrogacy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Donor Embryo Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Donor Embryo Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Donor Embryo Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Sperm Donation Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Sperm Donation Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Sperm Donation Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for 18-24 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for 18-24 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for 18-24 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for 25-34 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for 25-34 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for 25-34 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for 35-44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for 35-44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for 35-44 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for 45-54 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for 45-54 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for 45-54 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • JAPAN
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • CHINA
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • EUROPE
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Fertility Tourism by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Fertility Tourism by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Fertility Tourism by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • FRANCE
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • GERMANY
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Tourism by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Fertility Tourism by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Fertility Tourism by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • INDIA
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Fertility Tourism by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Fertility Tourism by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Fertility Tourism by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Fertility Tourism by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Fertility Tourism by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Fertility Tourism by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • AFRICA
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030

IV. COMPETITION